Recent developments in therapy for advanced BRAF mutation positive melanoma – Royal Australasian College of Surgeons

After completing this module, participants will have an enhanced understanding of:

1. The latest clinical data on metastatic melanoma treatment, with a focus on novel approaches such as combination BRAF inhibition with MEK inhibition, including recent combination trial results from the COMBI–d, COMBI–v and COBRIM trials
2. Specific adverse events (AEs) associated with these treatments and strategies to anticipate, identify, and manage these AEs.
3. The range of other novel therapies for advanced melanoma that are available and in development
4. New treatment algorithms and identification of appropriate metastatic melanoma patients as candidates for the latest therapies.